Chapter Abstracts
Chapter 20: Governance, Ethics and
Future Directions — Cybersecurity
and Data Privacy in Smart
Healthcare
The convergence of Industry 5.0 technologies with
healthcare delivery has produced an unprecedented
volume of sensitive patient data flowing across
interconnected devices, cloud platforms, and
artificial intelligence systems. This chapter
examines the governance structures, ethical
imperatives, and technical safeguards required to
secure this data ecosystem while preserving the
clinical and operational benefits that smart
healthcare technologies offer. As hospitals, clinics,
and remote monitoring systems increasingly rely on
Internet of Medical Things (IoMT) devices, wearable
biosensors, and AI-driven diagnostic tools, the
attack surface for cyber threats expands
correspondingly, exposing healthcare institutions to
risks ranging from ransomware attacks on hospital
networks to unauthorized access of electronic
health records and the potential manipulation of
connected medical devices.
The chapter begins by mapping the unique
vulnerabilities of healthcare cybersecurity relative
to other sectors. Unlike financial or retail systems,
healthcare infrastructure often integrates legacy
equipment with modern connected devices, creating
heterogeneous networks that are difficult to secure
uniformly. A hospital's infusion pump, for instance,
may operate on outdated firmware while
simultaneously transmitting data to a cloud-based
analytics platform—creating a weak link that
adversaries can exploit. The discussion extends to
real-world precedents, such as the WannaCry
ransomware attack that disrupted the UK's National
Health Service, illustrating how cybersecurity
failures translate directly into patient safety
incidents rather than merely financial or
reputational damage.
Central to the chapter is an exploration of data
privacy frameworks and their application to smart
healthcare contexts. Regulatory regimes such as the
Health Insurance Portability and Accountability
Act (HIPAA) in the United States and the General
Data Protection Regulation (GDPR) in the European
Union are analyzed not as static compliance
checklists but as evolving frameworks that must
adapt to novel data types—including continuous
biometric streams from wearables and genomic
data used in precision medicine. The chapter
highlights how traditional consent models, designed
for episodic clinical encounters, struggle to
accommodate the continuous, passive data
collection characteristic of IoMT ecosystems,
necessitating new approaches such as dynamic
consent and granular data-sharing permissions.
Governance mechanisms form a second major pillar
of the chapter. It examines institutional structures
—including hospital-level data governance
committees, national health data authorities, and
international standards bodies such as ISO/IEC
27001 for information security management—that
collectively shape how healthcare organizations
implement and enforce cybersecurity policy. A
practical example is offered through the analysis of
a hospital network implementing a zero-trust
architecture, wherein every device and user must be
continuously authenticated regardless of network
location, reflecting a shift away from perimeter-
based security models that are ill-suited to
distributed IoMT environments.
The chapter also addresses the ethical dimensions
of cybersecurity governance, particularly the
tension between data utility and privacy
protection. AI-driven predictive analytics systems
require large, high-quality datasets to function
effectively, creating pressure to aggregate and
share patient data across institutions. This chapter
discusses privacy-preserving techniques such as
federated learning, which allows machine learning
models to be trained across decentralized data
sources without the underlying data ever leaving
its original institution—illustrated through the
example of a multi-hospital consortium
collaboratively training a diagnostic model for rare
diseases without any single institution having to
relinquish control of its patient records.
Emerging threats specific to AI-enabled healthcare
systems receive dedicated attention, including
adversarial attacks designed to manipulate machine
learning model outputs (such as subtly altered
medical images causing a diagnostic AI to
misclassify a tumor), data poisoning attacks that
corrupt training datasets, and the risks associated
with third-party AI vendors accessing sensitive
clinical data. The chapter also considers the
cybersecurity implications of digital twins in
healthcare, where a virtual replica of a patient's
physiological state, if compromised, could lead to
incorrect treatment simulations or
recommendations.
Looking toward future directions, the chapter
discusses the role of blockchain technology in
creating tamper-evident audit trails for health data
access, the potential of homomorphic encryption to
enable computation on encrypted data without
decryption, and the growing importance of
cybersecurity insurance and incident response
planning as standard components of hospital risk
management. It closes by considering the workforce
dimension of healthcare cybersecurity—the need
for clinical staff training, dedicated health-sector
CISOs (Chief Information Security Officers), and
interdisciplinary collaboration between IT security
professionals and clinical practitioners.
For readers in regulatory affairs, ethics, and
healthcare governance, this chapter provides a
foundational understanding of how cybersecurity
and privacy considerations must be embedded into
the design, deployment, and oversight of smart
healthcare systems from the outset, rather than
treated as an afterthought. It offers a framework
for evaluating the adequacy of existing regulatory
instruments against the pace of technological
change, and for anticipating the governance
challenges that next-generation healthcare
technologies will present. The chapter ultimately
argues that robust cybersecurity and privacy
governance are not merely defensive measures but
foundational enablers of trust—without which the
broader promise of Industry 5.0 smart healthcare
cannot be responsibly realized.
Chapter 21: Ethical, Legal, and
Social Implications of AI-Driven
Healthcare
As artificial intelligence systems become embedded
in diagnostic, therapeutic, and administrative
healthcare processes, they raise profound questions
that extend well beyond technical performance
metrics. This chapter provides a comprehensive
examination of the ethical, legal, and social
implications (ELSI) of AI-driven healthcare,
situating these technologies within the broader
context of medical ethics, jurisprudence, and social
equity. Rather than treating AI as a purely
technical innovation, the chapter frames it as a
socio-technical intervention that reshapes clinical
relationships, redistributes accountability, and
interacts with pre-existing structural inequities in
healthcare access and delivery.
The chapter opens with an examination of core
bioethical principles—autonomy, beneficence, non-
maleficence, and justice—and how each is
complicated by AI integration. Patient autonomy,
for example, is challenged when AI-generated
recommendations are opaque to both clinicians and
patients, undermining informed consent. The
chapter illustrates this through the example of an
AI-based sepsis prediction tool that flags a patient
as high-risk without a clear explanation of which
clinical variables drove the alert, leaving the
treating physician unable to fully justify a
subsequent intervention to the patient or their
family. This leads into a discussion of the "black
box" problem and its ethical ramifications,
distinguishing between interpretability
(understanding how a model works) and
explainability (providing human-understandable
justifications for specific outputs).
A significant portion of the chapter addresses
algorithmic bias and fairness. AI models trained on
historical healthcare data can inherit and amplify
existing disparities—a well-documented example
being a widely used commercial risk-prediction
algorithm that systematically underestimated the
healthcare needs of Black patients because it used
historical healthcare spending as a proxy for health
need, disregarding the fact that unequal access to
care had suppressed spending among that
population. The chapter uses this case to illustrate
how technically "accurate" models can nonetheless
produce ethically unacceptable outcomes, and
discusses mitigation strategies including bias
audits, diverse training data curation, and fairness-
aware machine learning techniques.
Legal implications are addressed through an
analysis of liability frameworks in AI-assisted
clinical decision-making. The chapter examines the
ambiguity that arises when a diagnostic error
involves both a clinician's judgment and an AI
system's recommendation—asking who bears legal
responsibility: the treating physician, the hospital,
the software developer, or some shared
arrangement. It reviews evolving regulatory
approaches, such as the U.S. FDA's framework for
Software as a Medical Device (SaMD) and the EU's
AI Act's risk-based classification of medical AI
systems, using the example of an AI-powered
radiology tool that received regulatory clearance
for detecting one specific condition but was
subsequently used off-label for a broader diagnostic
purpose, creating legal exposure for the deploying
institution.
The social dimensions of AI-driven healthcare
receive equally rigorous treatment. The chapter
explores how AI adoption may exacerbate the
digital divide, disadvantaging populations with
limited digital literacy, unreliable internet access,
or distrust in technology-mediated care stemming
from historical medical mistreatment. It also
considers the transformation of the clinician-
patient relationship, examining concerns that over-
reliance on AI recommendations could erode clinical
reasoning skills over time—a phenomenon
sometimes termed "automation complacency,"
illustrated through studies of clinicians who, after
prolonged use of AI-assisted diagnostic tools,
showed reduced independent diagnostic accuracy
when the tools were temporarily unavailable.
Data ownership and commercialization form
another key theme, examining the ethical tensions
that arise when patient data used to train
commercially valuable AI models is contributed
without patients receiving any share of resulting
profits or clear visibility into how their data is
monetized. The chapter presents this through the
lens of biobank and health-data-sharing agreements,
where informed consent processes have historically
lagged behind the sophistication of downstream AI
applications.
The chapter closes by synthesizing these ethical,
legal, and social threads into practical guidance for
governance bodies, proposing a multi-stakeholder
oversight model involving clinicians, ethicists,
patient representatives, legal experts, and
technologists in the ongoing evaluation of AI
systems throughout their deployment lifecycle—not
merely at initial approval. For an audience engaged
in regulatory affairs and healthcare governance,
this chapter offers both a conceptual grounding in
the ethical stakes of AI-driven healthcare and a
practical vocabulary for identifying and addressing
ELSI concerns in policy design, procurement
decisions, and institutional oversight structures.
Chapter 22: Policy and Governance
Frameworks for Industry 5.0
Healthcare
This chapter provides a systematic analysis of the
policy and governance structures needed to guide
the responsible adoption of Industry 5.0
technologies within healthcare systems. Industry
5.0, distinguished from its predecessor Industry 4.0
by its explicit emphasis on human-centricity,
sustainability, and resilience, presents governance
challenges that extend beyond conventional health
technology regulation. Where earlier regulatory
frameworks were designed around discrete medical
devices with fixed functionality, Industry 5.0
healthcare technologies—spanning AI-integrated
robotics, digital twins, human-machine
collaborative systems, and adaptive IoMT networks
—continuously evolve post-deployment, demanding
governance models that are similarly dynamic and
adaptive rather than static and approval-based.
The chapter begins by outlining the foundational
principles that distinguish Industry 5.0 governance
from prior paradigms: human-centric design
mandates, circular economy and sustainability
requirements, and resilience against systemic
disruption. It illustrates these principles through
the example of a hospital deploying collaborative
robots (cobots) for medication delivery, where
governance frameworks must address not only
technical safety certification but also human
factors such as staff trust, workflow integration,
and the preservation of meaningful human
oversight in clinical decision points—reflecting the
human-centric pillar of Industry 5.0 rather than
pure automation efficiency.
A substantial portion of the chapter is devoted to
comparative analysis of existing regulatory
frameworks and their applicability to Industry 5.0
healthcare contexts. It examines the World Health
Organization's guidance on AI ethics and
governance in health, the European Union's AI Act
as applied to medical technologies, and national-
level initiatives such as the UK's AI and Digital
Regulations Service for health and social care. The
chapter uses the example of adaptive AI algorithms
that continue learning post-deployment (as opposed
to "locked" algorithms approved once and never
updated) to illustrate a specific governance gap:
most existing medical device regulatory
frameworks assume static functionality, and few
provide clear pathways for the ongoing
certification of systems whose behavior changes
over time based on new data.
The chapter then turns to institutional governance
mechanisms at the organizational level, discussing
how hospitals and health systems are establishing
internal AI governance committees, algorithmic
impact assessment processes, and technology
procurement standards specifically calibrated for
Industry 5.0 systems. A detailed example
illustrates a health system's implementation of a
tiered risk-assessment protocol for new technology
procurement, wherein a proposed digital twin
system for post-surgical monitoring is evaluated
not only for clinical efficacy but also for data
governance compliance, interoperability with
existing infrastructure, environmental impact of
computing resources, and workforce training
requirements before deployment approval is
granted.
International harmonization and standards
development receive dedicated attention, given that
Industry 5.0 healthcare technologies frequently
involve global supply chains and cross-border data
flows—wearable devices manufactured in one
jurisdiction, cloud infrastructure hosted in another,
and clinical deployment in a third, each subject to
different regulatory regimes. The chapter examines
the role of standards organizations such as ISO and
IEC in developing technical standards that can serve
as common reference points across jurisdictions,
using the example of ISO/IEC 42001 for AI
management systems as an emerging framework
that healthcare organizations can adopt to
demonstrate governance maturity even in the
absence of binding national legislation.
Sustainability governance forms another key theme,
reflecting the Industry 5.0 emphasis on
environmentally responsible innovation. The
chapter discusses policy mechanisms for evaluating
the environmental footprint of healthcare AI
systems—particularly the substantial energy
consumption associated with training and running
large-scale machine learning models—and examines
emerging "green health-tech" procurement criteria
that some health systems have begun incorporating
into technology acquisition policies.
The chapter concludes by proposing a multi-level
governance architecture spanning international
standards bodies, national regulators, and
institutional governance committees, arguing that
effective Industry 5.0 healthcare governance
requires coordinated action across all three levels
rather than reliance on any single regulatory
mechanism. It emphasizes the importance of
adaptive, iterative policy-making processes capable
of keeping pace with technological change, including
regulatory sandboxes that allow controlled real-
world testing of novel healthcare technologies
under regulatory supervision before full-scale
deployment. For readers involved in regulatory
affairs and healthcare policy, this chapter offers a
structured framework for understanding the
distinct governance demands of Industry 5.0
healthcare technologies and practical models for
institutional and national-level policy development.